Cargando…
TMEM106B a Novel Risk Factor for Frontotemporal Lobar Degeneration
Recently, the first genome-wide association (GWA) study in frontotemporal lobar degeneration (FTLD) identified common genetic variability at the TMEM106B gene on chromosome 7p21.3 as a potential important risk-modifying factor for FTLD with pathologic inclusions of TAR DNA-binding protein (FTLD-TDP)...
Autores principales: | van der Zee, Julie, Van Broeckhoven, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Humana Press Inc
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207134/ https://www.ncbi.nlm.nih.gov/pubmed/21614538 http://dx.doi.org/10.1007/s12031-011-9555-x |
Ejemplares similares
-
TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort
por: van der Zee, Julie, et al.
Publicado: (2011) -
The molecular basis of the frontotemporal lobar degeneration–amyotrophic lateral sclerosis spectrum
por: van Langenhove, Tim, et al.
Publicado: (2012) -
Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain
por: Busch, Johanna I, et al.
Publicado: (2013) -
The genetics and neuropathology of frontotemporal lobar degeneration
por: Sieben, Anne, et al.
Publicado: (2012) -
Lack of a protective effect of the Tmem106b “protective SNP” in the Grn knockout mouse model for frontotemporal lobar degeneration
por: Cabron, Anne-Sophie, et al.
Publicado: (2023)